A key marker of ALPS is a high proportion of CD4−CD8− TCRαβ+ T cells, called double-negative T cells, and increased plasma concentrations of soluble Fas-ligand with limited cytotoxicity potential to eliminate T cells. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.